This brand name is authorized in Australia, France, Lithuania, Netherlands, New Zealand, Tunisia
The drug KENACORT contains one active pharmaceutical ingredient (API):
|
1
Triamcinolone acetonide
UNII F446C597KA - TRIAMCINOLONE ACETONIDE
|
|
Triamcinolone acetonide is a more potent derivative of triamcinolone and is approximately 8 times more potent than prednisone. Although the precise mechanism of corticosteroid anti-allergic action is unknown, corticosteroids are very effective in the treatment of allergic diseases in man. Also, local injections are thought to have an anti-inflammatory effect. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A01AC01 | Triamcinolone | A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AC Corticosteroids for local oral treatment |
| D07AB09 | Triamcinolone | D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AB Corticosteroids, moderately potent (group II) |
| D07XB02 | Triamcinolone | D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07X Corticosteroids, other combinations → D07XB Corticosteroids, moderately potent, other combinations |
| H02AB08 | Triamcinolone | H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids |
| R01AD11 | Triamcinolone | R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AD Corticosteroids |
| R03BA06 | Triamcinolone | R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids |
| S01BA05 | Triamcinolone | S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BA Corticosteroids, plain |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 2990J, 5233K |
| Country: FR | Base de données publique des médicaments | Identifier(s): 62899127, 65061047 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1093220 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 12128163, 12128171, 13754726 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 107085, 73105, 73121, 73148 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 107, 109 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 6400041 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
